ARA-290

ARA-290 is a synthetic peptide derived from erythropoietin (EPO) but designed to avoid stimulating red blood cell production.
It primarily targets the CD131 receptor, activating tissue-protective pathways without hematopoietic side effects.
ARA-290 is known for its potent anti-inflammatory and neuroprotective properties.
It has been researched for treating neuropathic pain, diabetic complications, and autoimmune inflammation.
The peptide promotes nerve repair, improves insulin sensitivity, and reduces oxidative stress.
Overall, ARA-290 acts as a regenerative and protective agent for damaged tissues and nerves.